医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Foreign body accidentally left during injection/immunization. Emergency care is used.
Adverse effect of immune globulins. Symptom management is used.
Adverse effect of tetanus vaccine. Symptom management is used.
Adverse effect of antirheumatic drugs. Symptom management is used.
Adverse effect of immunosuppressants. Symptom management is used.
Poisoning by non-opioid analgesic/antipyretic/antirheumatic, intent unknown. Poison control is used.
Intentional self-poisoning by non-opioid analgesic/antipyretic/antirheumatic. Poison control and psychiatry care are used.
Accidental poisoning by non-opioid analgesic, antipyretic or antirheumatic. Gastric decontamination and supportive care are used.
Victim of storm. Emergency rescue is used.
Erythema marginatum due to acute rheumatic fever. Antirheumatic therapy is used.
HIV encephalopathy dementia. Antiretroviral therapy and supportive care are used.
Serum sickness is immune complex reaction, from serum/antitoxin exposure. Antihistamines/steroids are used.
风湿免疫科In 1980, Winklemann et al. first proposed the name histiocytic phagocytic panniculitis and reported 5 cases. It is a benign histiocytic proliferative disease characterized by generalized tender multiple subcutaneous nodules, high fever, hepatosplenomegaly
风湿免疫科Rheumatism is a group of diseases mainly involving the joints, bones, muscles, blood vessels and related soft or connective tissue, most of which are autoimmune. Onset is often insidious and slow, the course is long, and most have a genetic tendency. Diag
风湿免疫科AS is chronic inflammatory spondyloarthritis (HLA-B27+); NSAIDs, TNF/iFoxi inhibitors, sulfasalazine, PT, exercise; monitor uveitis/IBD; follow-up rheumatology.
风湿免疫科Autoimmune disease (M35.907) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
IgG4-related disease (M35.906) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Anti-Jo-1 syndrome (M35.905) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Connective tissue disease pulmonary interstitial fibrosis () is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is
Collagen-vascular polyneuropathy () is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
|
